Researchers found that roughly 30% of chlamydia and gonorrhea patients did not receive treatment, while only 14% and 39% received recommended antibiotics.
Researchers found "exceedingly high" levels of gonococcal tetracycline resistance in 8 African and Asian countries.
Researchers find a marked increase in tetracycline-resistant gonorrhea and increased colonization with tetracycline-resistant Staphylococcus aureus following the rollout of doxyPEP.
Among patients prescribed doxycycline post-exposure prophylaxis, cases of syphilis, chlamydia, and gonorrhea fell by 86.4%. 89.7%, and 54.7%, respectively.
The rate of gonorrhea cases across Europe rose by 31% in 2023 compared with 2022, and is up 321% since 2014.
Two studies in California found significant reductions in chlamydia and syphilis in the year after doxycycline post-exposure prophylaxis guidelines were released.
The partnership will evaluate the clinical need and address market barriers for diagnostic, therapeutic, and preventive interventions for gonorrhea in low-resource countries.
The number of STIs declined almost 2% from 2022 to 2023, a sign that the dramatic rise in STIs since 2011 might be leveling off.
The global health organization says the lack of rapid diagnostic tests results in undertreatment and overtreatment of gonorrhea in low-resource nations
Most of the infections have been acquired abroad, and transmission in England has been limited, but officials are worried about the potential for wider spread.
